Send feedback

MTM1 p.Cys113=

c.339T>C · rs147644722 · VCV285094

Benign Expert panel
Classification
Benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 6 submitters
gnomAD v4.1
Rare
rare (popmax 0.366%, afr)
Conditions
2
centronuclear myopathy

ClinGen expert panel — Congenital Myopathies VCEP

Benign for centronuclear myopathy. Applied ACMG criteria (verbatim):

BP7 BP4 BA1

Curation rationale (ClinGen, verbatim)

The variant NM_000252.3:c.339T>C in MTM1 is a synonymous (silent) variant (p.Cys113=). The highest population filtering allele frequency in gnomAD v4.1.0 is 0.003242 (198/54107 alleles, 58 hemizygotes) in African/African American population, which is higher than the ClinGen Congenital Myopathies VCEP threshold (≥0.000016) for BA1, and therefore meets this criterion (BA1). In addition, SpliceAI does not predict impact to splicing, and the variant occurs at a nucleotide that is not conserved as shown by UCSC Genome Browser (BP4, BP7). In summary, this variant meets the criteria to be classified as benign for X-linked centronuclear myopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: BA1, BP4, BP7. (Congenital Myopathies VCEP specifications version 1; 8/7/2024)

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2.3GERP 1.9, phastCons 1
Overall
CADD10.92PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.366% African / African-American · 198/54,107 alleles
Filtering AF 0.324% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.308%
Overall 0.0229% 242/1,058,315 alleles · rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.366% 273
Admixed American 0.0553% 1,808
Remaining individualsnot grpmax-eligible 0.0328% 3,053
European (non-Finnish) 0.000659% 151,796

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MTM1
Protein
p.Cys113=
Coding
c.339T>C
MANE Select
NM_000252
dbSNP
rs147644722
Type
single nucleotide variant
Location
chrX:150614696 (GRCh38)
Structure
AlphaFold pLDDT 90.10
Full MTM1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mtm1-p-cys113 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown